Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...

Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified why certain lung cancer cells ...

When lung cancer treatment stops working, what happens next? New research reveals the answer may depend on how the cancer ...

Jorge Manchola, a retired Air Force staff sergeant, was diagnosed with stage 4 lung cancer in 2023. The cancer had spread to ...

Dr Mark Kris discusses the increasing precision of lung cancer therapies and the need for additional testing to find ...

WAUSAU, Wis. (WSAW) - In the past, being diagnosed with small-cell lung cancer seemed to be a death sentence. This type of cancer is known as one of the most aggressive and deadliest forms of cancer.

In a media release on Jan. 22, it was revealed that a group of scientists from the Agency for Science, Technology and ...

Anktiva, also known as nogapendekin alfa inbakicept, is a new cancer therapy that boosts the immune system to target cancer ...

Gainor highlighted that anyone can develop lung cancer, including people who have never smoked, and addressed the stigma that ...

VCU Massey is the first U.S. site in a global phase 2a trial for PTX-100, targeting cutaneous T-cell lymphoma. The BIPAVE-001 trial is evaluating AI-081, a PD-1 and VEGF bispecific antibody, for ...

Advances in lung cancer treatment have changed survival in ways that were unimaginable even a decade ago. Targeted drugs, ...

Thanks to recent therapy advances, the lung cancer mortality rate has declined and survival rates have improved. Many factors influence the likelihood of a lung cancer cure or long-term survival, ...